In vivo application and tracking of Baculovirus

Current Gene Therapy

Volumn 10, Issue 3, 2010, Pages 187-194

  Airenne, Kari J ^a   Makkonen, Kaisa Emilia ^a   Mähönen, Anssi J ^a   Ylä Herttuala, Seppo ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

BacMam; Baculoviruses; Gene therapy; Imaging; Transduction

Indexed keywords

APOPTIN; BACULOVIRUS VECTOR; DIPHTHERIA TOXIN; GANCICLOVIR; PROTEIN BRLF1; THYMIDINE KINASE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; AUTOGRAPHA CALIFORNICA MULTIPLE NUCLEOPOLYHEDROVIRUS; BACULOVIRUS; EXPERIMENTAL NEOPLASM; FLUORESCENCE IMAGING; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; GLIOBLASTOMA; HUMAN; IN VIVO GENE TRANSFER; LIVER CELL CARCINOMA; NASOPHARYNX CARCINOMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RNA INTERFERENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUICIDE GENE THERAPY; VACCINE PRODUCTION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRION;

BACULOVIRIDAE; CLINICAL PROTOCOLS; CLINICAL TRIALS AS TOPIC; DOSAGE FORMS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS;

VERTEBRATA;

EID: 77953671176     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652310791321206     Document Type: Article

References (109)

1. Miller LK. The Baculoviruses. Plenum Press: New York, 1997.
2. Airenne KJ, Mähönen AJ, Laitinen OH, Ylä-Herttuala.S. Baculovirus-mediated gene transfer: an emerging universal concept. In: Templeton NS, Ed. Gene and cell therapy: therapeutic mechanisms and strategies. Boca Raton: CRC Press 2009; pp. 263-307.
3. Volkman LE. Baculovirus infectivity and the actin cytoskeleton. Curr Drug Targets 2007; 8: 1075-83.
4. Theilmann DA, Blissard GW, Bonning B et al. Family Baculoviridae. In: Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA Eds. Virus taxonomy: eight report of the international committee on taxonomy of viruses. London: Elsevier 2005; pp. 177-85.
5. Miller LK, Lu A. The molecular basis of baculovirus host range. In: Miller LK Ed. The Baculoviruses. New York: Plenum Press 1997; pp. 217-35.
6. Burges HD, Croizier G., Huger J. A review of safety tests on baculoviruses. Entomaphaga 1980; 25: 329-40.
7. Summers MD. Milestones leading to the genetic engineering of baculoviruses as expression vector systems and viral pesticides. Adv Virus Res 2006; 68: 3-73.
8. O'Reilly DR, Miller LK, Luckov VA. Baculovirus expression vectors: a laboratory manual. New York: Oxford University Press 1994.
9. Kost TA, Condreay JP, Jarvis DL. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 2005; 23: 567-75.
10. Volkman LE, Goldsmith PA. In vitro Survey of Autographa californica nuclear polyhedrosis virus interaction with nontarget vertebrate host cells. Appl Environ Microbiol 1983; 45: 1085-93.
11. Hofmann C, Sandig V, Jennings G, et al. Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc Natl Acad Sci USA 1995; 92: 10099-103.
12. Boyce FM,.Bucher NL. Baculovirus-mediated gene transfer into mammalian cells. Proc Natl Acad Sci USA 1996; 93: 2348-52.
13. Hu YC. Baculoviral vectors for gene delivery: a review. Curr Gene Ther 2008; 8: 54-65.
14. Tani H, Abe T, Matsunaga TM, Moriishi K, Matsuura Y. Baculovirus vector for gene delivery and vaccine development. Future Virol 2008; 3: 35-43.
15. Vicente T, Peixoto C, Carrondo MJ, Alves PM. Purification of recombinant Baculoviruses for gene therapy using membrane processes. Gene Ther 2009; 16: 766-75.
16. Du J, Zeng J, Zhao Y, Boulaire J, Wang S. The combined use of viral transcriptional and post-transcriptional regulatory elements to improve baculovirus-mediated transient gene expression in human embryonic stem cells. J Biosci Bioeng 2010; 109: 1-8.
17. Zeng J, Du J, Lin J, et al. High-efficiency transient transduction of human embryonic stem cell-derived neurons with baculoviral vectors. Mol Ther 2009; 17: 1585-93.
18. Lin CY, Chang YH, Lin KJ, et al. The healing of critical-sized femoral segmental bone defects in rabbits using baculovirus-engineered mesenchymal stem cells. Biomaterials 2010; 31: 3222-30.
19. Chen HC, Chang YH, Chuang CK, et al. The repair of osteochondral defects using baculovirus-mediated gene transfer with de-differentiated chondrocytes in bioreactor culture. Biomaterials 2009; 30: 674-81.
20. Zeng J, Du J, Zhao Y, Palanisamy N, Wang S. Baculoviral vector-mediated transient and stable transgene expression in human embryonic stem cells. Stem Cells 2007; 25: 1055-61.
21. Chuang CK, Sung LY, Hwang SM, et al. Baculovirus as a new gene delivery vector for stem cell engineering and bone tissue engineering. Gene Ther 2007; 14: 1417-24.
22. Hu YC, Yao K, Wu TY. Baculovirus as an expression and/or delivery vehicle for vaccine antigens. Expert Rev Vaccines 2008; 7: 363-71.
23. Lesch HP, Turpeinen S, Niskanen EA, et al. Generation of lentivirus vectors using recombinant Baculoviruses. Gene Ther 2008; 15: 1280-6.
24. Huang KS, Lo WH, Chung YC, et al. Combination of baculovirus-mediated gene delivery and packed-bed reactor for scalable production of adeno-associated virus. Hum Gene Ther 2007; 18: 1161-70.
25. Smith RH, Levy JR, Kotin RM. A Simplified Baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells. Mol Ther 2009; 17: 1888-96.
26. Ayres MD, Howard SC, Kuzio J, Lopez-Ferber M, Possee RD. The complete DNA sequence of Autographa californica nuclear polyhedrosis virus. Virology 1994; 202: 586-605.
27. Funk CJ, Braunagel SC, Rohrmann GF. Baculovirus Structure. In: Miller LK, Ed. The Baculoviruses. Plenum Press: New York 1997; pp. 7-32.
28. Kost TA,.Condreay JP. Innovations-Biotechnology: Baculovirus vectors as gene transfer vectors for mammlian cells: biosafety considerations. J Am Biol Saf Ass 2002; 7: 167-9.
29. Hartley JL. Cloning technologies for protein expression and purification. Curr Opin Biotechnol 2006; 17: 359-66.
30. Airenne KJ, Peltomaa E, Hytonen VP, Laitinen OH, Yla-Herttuala S. Improved generation of recombinant baculovirus genomes in Escherichia coli. Nucleic Acids Res 2003; 31: e101.
31. Airenne KJ, Laitinen OH, Mahonen AJ, Ylä-Herttuala.S. Safe, Simple, and High-capacity gene delivery into insect and vertebrate cells by recombinant baculoviruses. In: Friedmann T, Rossi J, Eds. gene transfer: delivery and expression of DNA and RNA. New York: Cold Spring Harbor laboratory Press 2007; pp. 313-25.
32. Laitinen OH, Airenne KJ, Hytonen VP, et al. A multipurpose vector system for the screening of libraries in bacteria, insect and mammalian cells and expression in vivo. Nucleic Acids Res 2005; 33: e42.
33. Granados RR. Replication phenomena of insect viruses in vivo and in vitro. In: Miltenburger HG, Ed. Safety aspects of baculoviruses as biological insecticides. Bonn: Bundesministerium fur Forschung und Technologie 1978; pp. 163-84.
34. Jarvis DL, Garcia A, Jr. Long-term stability of baculoviruses stored under various conditions. Biotechniques 1994; 16: 508-13.
35. Andersson M, Warolen M, Nilsson J, et al. Baculovirus-mediated gene transfer and recombinant protein expression do not interfere with insulin dependent phosphorylation of PKB/Akt in human SHSY-5Y and C3A cells. BMC Cell Biol 2007; 8: 6.
36. van Loo ND, Fortunati E, Ehlert E, et al. Baculovirus infection of nondividing mammalian cells: mechanisms of entry and nuclear transport of capsids. J Virol 2001; 75: 961-70.
37. Laakkonen JP, Kaikkonen MU, Ronkainen PH, et al. Baculovirus-mediated immediate-early gene expression and nuclear reorganization in human cells. Cell Microbiol 2008; 10: 667-81.
38. Kinnunen K, Kalesnykas G, Mahonen AJ, et al. Baculovirus is an efficient vector for the transduction of the eye: comparison of baculovirus- and adenovirus-mediated intravitreal vascular endothelial growth factor D gene transfer in the rabbit eye. J Gene Med 2009; 11: 382-9.
39. Strauss R, Huser A, Ni S, et al. Baculovirus-based vaccination vectors allow for efficient induction of immune responses against Plasmodium falciparum circumsporozoite protein. Mol Ther 2007; 15: 193-202.
40. Harper DM, Franco EL, Wheeler C, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004; 364: 1757-65.
41. Condreay JP, Witherspoon SM, Clay WC, Kost TA. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc Natl Acad Sci USA 1999; 96: 127-32.
42. Song SU, Shin SH, Kim SK, et al. Effective transduction of osteogenic sarcoma cells by a baculovirus vector. J Gen Virol 2003; 84: 697-703.
43. Cheng T, Xu CY, Wang YB, et al. A rapid and efficient method to express target genes in mammalian cells by baculovirus. World J Gastroenterol 2004; 10: 1612-8.
44. Kost TA, Condreay JP, Ames RS, Rees S, Romanos MA. Implementation of BacMam virus gene delivery technology in a drug discovery setting. Drug Discov Today 2007; 12: 396-403.
45. Oker-Blom C, Airenne KJ, Grabherr R. Baculovirus display strategies: emerging tools for eukaryotic libraries and gene delivery. Brief Funct Genomic Proteomic 2003; 2: 244-53.
46. Wu C, Lin J, Hong M et al. Combinatorial control of suicide gene expression by tissue-specific promoter and microRNA regulation for cancer therapy. Mol Ther 2009; 17: 2058-66.
47. Airenne KJ, Hiltunen MO, Turunen MP, et al. Baculovirus-mediated periadventitial gene transfer to rabbit carotid artery. Gene Ther 2000; 7: 1499-504.
48. Black BC, Brennan LA, Dierks PM, Gard IE. Commercialization of Baculoviral insecticides. In: Miller LK Ed. The Baculoviruses, New York: Plenum Press 1997; pp. 341-87.
49. Blissard GW. Baculovirus-insect cell interactions. Cytotechnology 1996; 20: 73-93.
50. Matilainen H, Rinne J, Gilbert L, et al. Baculovirus entry into human hepatoma cells. J Virol 2005; 79: 15452-9.
51. Wang P, Hammer DA, Granados RR. Binding and fusion of Autographa californica nucleopolyhedrovirus to cultured insect cells. J Gen Virol 1997; 78: 3081-9.
52. Long G, Pan X, Kormelink R, Vlak JM. Functional entry of baculovirus into insect and mammalian cells is dependent on clathrin-mediated endocytosis. J Virol 2006; 80: 8830-3.
53. Laakkonen JP, Makela AR, Kakkonen E, et al. Clathrin-independent entry of baculovirus triggers uptake of E. coli in non-phagocytic human cells. PLoS One 2009; 4: e5093.
54. Blissard GW, Wenz JR. Baculovirus gp64 envelope glycoprotein is sufficient to mediate pH-dependent membrane fusion. J Virol 1992; 66: 6829-35.
55. Kukkonen SP, Airenne KJ, Marjomaki V, et al. Baculovirus capsid display: a novel tool for transduction imaging. Mol Ther 2003; 8:853-62.
56. Mahonen AJ, Makkonen KE, Laakkonen JP, et al. Culture medium induced vimentin reorganization associates with enhanced baculovirus-mediated gene delivery. J Biotechnol 2010; 145: 111-9.
57. Kitajima M, Hamazaki H, Miyano-Kurosaki N, Takaku H. Characterization of baculovirus Autographa californica multiple nuclear polyhedrosis virus infection in mammalian cells. Biochem Biophys Res Commun 2006; 343: 378-84.
58. Salminen M, Airenne KJ, Rinnankoski R, et al. Improvement in nuclear entry and transgene expression of baculoviruses by disintegration of microtubules in human hepatocytes. J Virol 2005; 79: 2720-8.
59. Barsoum J, Brown R, McKee M, Boyce FM. Efficient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein. Hum Gene Ther 1997; 8: 2011-8.
60. Kaikkonen MU, Raty JK, Airenne KJ, et al. Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo. Gene Ther 2006; 13: 304-12.
61. Mahonen AJ, Airenne KJ, Purola S, et al. Post-transcriptional regulatory element boosts baculovirus-mediated gene expression in vertebrate cells. J Biotechnol 2007; 131: 1-8.
62. Hsu CS, Ho YC, Wang KC, Hu YC. Investigation of optimal transduction conditions for baculovirus-mediated gene delivery into mammalian cells. Biotechnol Bioeng 2004; 88: 42-51.
63. Airenne KJ. Optimization of baculovirus-mediated gene delivery into vertebrate cells. BioProcessing J 2009; 8: 54-9.
64. Raty JK, Liimatainen T, Huhtala T, et al. SPECT/CT imaging of baculovirus biodistribution in rat. Gene Ther 2007; 14: 930-8.
65. Raty JK, Liimatainen T, Kaikkonen MU, et al. Non-invasive Imaging in Gene Therapy. Mol Ther 2007; 15: 1579-86.
66. Raty JK, Liimatainen T, Wirth T, et al. Magnetic resonance imaging of viral particle biodistribution in vivo. Gene Ther 2006; 13: 1440-6.
67. Li Y, Wang X, Guo H, Wang S. Axonal transport of recombinant baculovirus vectors. Mol Ther 2004; 10: 1121-9.
68. Mottershead D, van dL, I, von Bonsdorff CH, Keinanen K, Oker-Blom C. Baculoviral display of the green fluorescent protein and rubella virus envelope proteins. Biochem Biophys Res Commun 1997; 238: 717-22.
69. Raty JK, Airenne KJ, Marttila AT, et al. Enhanced gene delivery by avidin-displaying baculovirus. Mol Ther 2004; 9: 282-91.
70. Kaikkonen MU, Viholainen JI, Narvanen A, Yla-Herttuala S, Airenne KJ. Targeting and purification of metabolically biotinylated baculovirus. Hum Gene Ther 2008; 19: 589-600.
71. Wilchek M, Bayer EA. Introduction to avidin-biotin technology. Methods Enzymol 1990; 184: 5-13.
72. Laitinen OH, Nordlund HR, Hytonen VP, Kulomaa MS. Brave new (strept)avidins in biotechnology. Trends Biotechnol 2007; 25: 269-77.
73. Lehtolainen P, Tyynela K, Kannasto J, Airenne KJ, Yla-Herttuala S. Baculoviruses exhibit restricted cell type specificity in rat brain: a comparison of baculovirus-and adenovirus-mediated intracerebral gene transfer in vivo. Gene Ther 2002; 9: 1693-9.
74. Kaikkonen MU, Lesch HP, Pikkarainen J, et al. (Strept)avidin-displaying lentiviruses as versatile tools for targeting and dual imaging of gene delivery. Gene Ther 2009; 16: 894-904.
75. Sandig V, Hofmann C, Steinert S, et al. Gene transfer into hepatocytes and human liver tissue by baculovirus vectors. Hum Gene Ther 1996; 7: 1937-45.
76. Hofmann C, Strauss M. Baculovirus-mediated gene transfer in the presence of human serum or blood facilitated by inhibition of the complement system. Gene Ther 1998; 5: 531-6.
77. Georgopoulos LJ, Elgue G, Sanchez J, et al. Preclinical evaluation of innate immunity to baculovirus gene therapy vectors in whole human blood. Mol Immunol 2009; 46: 2911-7.
78. Hoare J, Waddington S, Thomas HC, Coutelle C, McGarvey MJ. Complement inhibition rescued mice allowing observation of transgene expression following intraportal delivery of baculovirus in mice. J Gene Med 2005; 7: 325-33.
79. Hofmann C, Wolfgang L, Strauss M. The Baculovirus vector system for gene delivery into hepatocytes. Gene Ther Mol Biol 1998; 1: 231-9.
80. Kircheis R, Wightman L, Schreiber A, et al. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther 2001; 8: 28-40.
81. Sarkis C, Serguera C, Petres S, et al. Efficient transduction of neural cells in vitro and in vivo by a baculovirus-derived vector. Proc Natl Acad Sci USA 2000; 97: 14638-43.
82. Hüser A, Rudolph M, Hofmann C. Incorporation of decay-accelerating factor into the baculovirus envelope generates complement-resistant gene transfer vectors. Nat Biotechnol 2001; 19: 451-5.
83. Kaikkonen MU, Maatta AI, Yla-Herttuala S, Airenne KJ. Screening of complement inhibitors: shielded baculoviruses increase the safety and efficacy of gene delivery. Mol Ther 2010; [Epub ahead of print].
84. Regev L, Ezrielev E, Gershon E, Gil S, Chen A. Genetic approach for intracerebroventricular delivery. Proc Natl Acad Sci USA 2010; [Epub ahead of print].
85. Tani H, Limn CK, Yap CC, et al. In vitro and in vivo gene delivery by recombinant baculoviruses. J Virol 2003; 77: 9799-808.
86. Pieroni L, Maione D, La Monica N. In vivo gene transfer in mouse skeletal muscle mediated by baculovirus vectors. Hum Gene Ther 2001; 12: 871-81.
87. Kim YK, Park IK, Jiang HL et al. Regulation of transduction efficiency by pegylation of baculovirus vector in vitro and in vivo. J Biotechnol 2006; 125: 104-9.
88. Yang Y, Lo SL, Yang J, et al. Polyethylenimine coating to produce serum-resistant baculoviral vectors for in vivo gene delivery. Biomaterials 2009; 30: 5767-74.
89. Li Y, Yang Y, Wang S. Neuronal gene transfer by baculovirus-derived vectors accommodating a neurone-specific promoter. Exp Physiol 2005; 90: 39-44.
90. Wang CY, Wang S. Astrocytic expression of transgene in the rat brain mediated by baculovirus vectors containing an astrocyte-specific promoter. Gene Ther 2006; 13: 1447-56.
91. Wang CY, Wang S. Adeno-associated virus inverted terminal repeats improve neuronal transgene expression mediated by baculoviral vectors in rat brain. Hum Gene Ther 2005; 16: 1219-26.
92. Liu BH, Yang Y, Paton JF, et al. GAL4-NF-kappaB fusion protein augments transgene expression from neuronal promoters in the rat brain. Mol Ther 2006; 14: 872-82.
93. Liu X, Li K, Song J, et al. Efficient and stable gene expression in rabbit intervertebral disc cells transduced with a recombinant baculovirus vector. Spine 2006; 31: 732-5.
94. Wang X, Wang C, Zeng J, et al. Gene transfer to dorsal root ganglia by intrathecal injection: effects on regeneration of peripheral nerves. Mol Ther 2005; 12: 314-20.
95. Park HJ, Lee WY, Kim JH, et al. Interstitial tissue-specific gene expression in mouse testis by intra-tunica albuguineal injection of recombinant baculovirus. Asian J Androl 2009; 11: 342-50.
96. Haeseleer F, Imanishi Y, Saperstein DA, Palczewski K. Gene transfer mediated by recombinant baculovirus into mouse eye. Invest Ophthalmol Vis Sci 2001; 42: 3294-300.
97. Luz-Madrigal A, Clapp C, Aranda J, Vaca L. In vivo transcriptional targeting into the retinal vasculature using recombinant baculovirus carrying the human flt-1 promoter. Virol J 2007; 4: 88.
98. Wang CY, Li F, Yang Y, et al. Recombinant baculovirus containing the diphtheria toxin A gene for malignant glioma therapy. Cancer Res 2006; 66: 5798-806.
99. Ong ST, Li F, Du J, Tan YW, Wang S. Hybrid cytomegalovirus enhancer-h1 promoter-based plasmid and Baculovirus vectors mediate effective RNA interference. Hum Gene Ther 2005; 16: 1404-12.
100. Balani P, Boulaire J, Zhao Y, et al. High mobility group box2 promoter-controlled suicide gene expression enables targeted glioblastoma treatment. Mol Ther 2009; 17: 1003-11.
101. Huang W, Tian XL, Wu YL, et al. Suppression of gastric cancer growth by baculovirus vector-mediated transfer of normal epithelial cell specific-1 gene. World J Gastroenterol 2008; 14: 5810-5.
102. Wang L, Shan L, Lo KW, et al. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing Baculovirus vectors containing oriP. J Gene Med 2008; 10: 1124-33.
103. Pan Y, Fang L, Fan H, et al. Antitumor effects of a recombinant pseudotype baculovirus expressing Apoptin in vitro and in vivo. Int J Cancer 2010; 126: 2741-51.
104. Makela AR, Enback J, Laakkonen JP, et al. Tumor targeting of baculovirus displaying a lymphatic homing peptide. J Gene Med 2008; 10: 1019-31.
105. Ando T, Fujiyuki T, Kawashima T, et al. In vivo gene transfer into the honeybee using a nucleopolyhedrovirus vector. Biochem Biophys Res Commun 2007; 352: 335-40.
106. Wagle M, Jesuthasan S. Baculovirus-mediated gene expression in zebrafish. Mar Biotechnol (NY) 2003; 5: 58-63.
107. Wagle M, Grunewald B, Subburaju S, et al. EphrinB2a in the zebrafish retinotectal system. J Neurobiol 2004; 59: 57-65.
108. Kitajima M, Abe T, Miyano-Kurosaki N, et al. Induction of natural killer cell-dependent antitumor immunity by the Autographa californica multiple nuclear polyhedrosis virus. Mol Ther 2008; 16: 261-8.
109. Nishibe Y, Kaneko H, Suzuki H, et al. Baculovirus-mediated interferon alleviates dimethylnitrosamine-induced liver cirrhosis symptoms in a murine model. Gene Ther 2008; 15: 990-7.